Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT)

CUSIP: 45258J102

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
202,731,676
Total 13F shares
94,088,777
Share change
+14,628,339
Total reported value
$1,608,317,726
Put/Call ratio
97%
Price per share
$17.09
Number of holders
191
Value change
+$221,642,111
Number of buys
125
Number of sells
71

Quarterly Holders Quick Answers

What is CUSIP 45258J102?
CUSIP 45258J102 identifies IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q1 2025

As of 31 Mar 2025, Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) was held by 191 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 94,088,777 shares. The largest 10 holders included FMR LLC, Deep Track Capital, LP, VANGUARD GROUP INC, T. Rowe Price Investment Management, Inc., BAKER BROS. ADVISORS LP, BlackRock, Inc., ARMISTICE CAPITAL, LLC, STATE STREET CORP, PERCEPTIVE ADVISORS LLC, and Alpine Global Management, LLC. This page lists 191 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.